Inhibiting a protein found to reduce progression of Alzheimer's and ALS in mice

August 17, 2017 by Bob Yirka, Medical Xpress report
Credit: CC0 Public Domain

(Medical Xpress)—A team of researchers with Genetech Inc. and universities in Hamburg and San Francisco has found that inhibiting the creation of a protein leads to a reduction in the progression of Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) in mice models. In their paper published in the journal Science Translational Medicine, the team describes the protein, how it works and their hopes for a clinical trial they have begun.

AD and ALS are very different brain disorders, of course, but they do have one thing in common—both are the result of losing brain cells. Scientists have been hard at work looking for ways to prevent and cure these ailments, but to date, there is no cure. Scientists also seek ways to delay the progression of both disorders to give patients more healthy years. In this new effort, the researchers report that inhibiting the production of a called dual leucine zipper kinase (DLK) in genetically altered to have AD or ALS slowed the progression of both diseases.

Prior research has shown that DLK is one of the regulators of neurodegeneration in both ALS and AD, and that it also activates another protein called c-Jun N-terminal kinase (JNK). That is a problem, because JNK is one of the agents involved in causing to die. The researchers with this new effort first conducted experiments showing elevated levels of both DLK and JNK in humans and mice with AD or ALS. They then genetically altered mice to remove the gene responsible for creating DLK and found that those mice with induced ALS experienced less neuron loss. The team next developed two drugs that inhibit DLK production, both of which were found to reduce JLK levels in mouse models. One of them was also found to reduce the progression of ALS in mice.

Pleased with their results thus far, Genetech has already launched a phase 1 clinical trial to test the drugs on human patients. They were able to move so quickly because DLK is a kinase, which means it belongs to a group of targets that have been deemed "very druggable."

Explore further: Laser used to reawaken lost memories in mice with Alzheimer's disease

More information: Claire E. Le Pichon et al. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease, Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aag0394

Hallmarks of chronic neurodegenerative disease include progressive synaptic loss and neuronal cell death, yet the cellular pathways that underlie these processes remain largely undefined. We provide evidence that dual leucine zipper kinase (DLK) is an essential regulator of the progressive neurodegeneration that occurs in amyotrophic lateral sclerosis and Alzheimer's disease. We demonstrate that DLK/c-Jun N-terminal kinase signaling was increased in mouse models and human patients with these disorders and that genetic deletion of DLK protected against axon degeneration, neuronal loss, and functional decline in vivo. Furthermore, pharmacological inhibition of DLK activity was sufficient to attenuate the neuronal stress response and to provide functional benefit even in the presence of ongoing disease. These findings demonstrate that pathological activation of DLK is a conserved mechanism that regulates neurodegeneration and suggest that DLK inhibition may be a potential approach to treat multiple neurodegenerative diseases.

Related Stories

Laser used to reawaken lost memories in mice with Alzheimer's disease

July 26, 2017
(Medical Xpress)—A team of researchers at Columbia University has found that applying a laser to the part of a mouse brain used for memory storage caused the mice to recall memories lost due to a mouse version of Alzheimer's ...

Scientists discover two repurposed drugs that arrest neurodegeneration in mice

April 20, 2017
A team of scientists who a few years ago identified a major pathway that leads to brain cell death in mice, have now found two drugs that block the pathway and prevent neurodegeneration. The drugs caused minimal side effects ...

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Possible genetic marker for ALS found might prove useful for measuring effectiveness of treatments

March 30, 2017
(Medical Xpress)—A very large team of researchers with members from the U.S., Italy and the Netherlands has found what might be a marker for ALS, which the team suggests could be used as a yardstick for measuring the effectiveness ...

Suppressing single protein greatly extends life span of mice with form of ALS

April 13, 2017
A study led by researchers at Stanford University School of Medicine has revealed a possible new therapeutic approach for amyotrophic lateral sclerosis, a progressive neurodegenerative disease.

Discovery opens door to new Alzheimer's treatments

November 17, 2016
Australian researchers have shed new light on the nerve cell processes that lead to Alzheimer's disease (AD), overturning previously held ideas of how the disease develops and opening the door to new treatment options that ...

Recommended for you

Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning

March 21, 2018
A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal ...

Immune cells in the retina can spontaneously regenerate

March 21, 2018
Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute (NEI). The cells also re-establish ...

Cold can activate body's 'good' fat at a cellular level, study finds

March 21, 2018
Lower temperatures can activate the body's 'good' fat formation at a cellular level, a new study led by academics at The University of Nottingham has found.

Switch discovered to convert blood vessels to blood stem cells in embryonic development

March 20, 2018
A switch has been discovered that instructs blood vessel cells to become blood stem cells during embryonic development in mice. Using single-cell technology, researchers from the Wellcome Sanger Institute in Cambridge and ...

Don't blame adolescent social behavior on hormones

March 19, 2018
Reproductive hormones that develop during puberty are not responsible for changes in social behavior that occur during adolescence, according to the results of a newly published study by a University at Buffalo researcher.

Stem cells treat macular degeneration

March 19, 2018
In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.